TMDI - Titan Medical Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
16.71M
Enterprise Value 3
24.57M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-0.39

Trading Information

Stock Price History

Beta (3Y Monthly) 4.46
52-Week Change 3-71.87%
S&P500 52-Week Change 38.78%
52 Week High 34.6500
52 Week Low 30.5000
50-Day Moving Average 31.5056
200-Day Moving Average 32.1541

Share Statistics

Avg Vol (3 month) 3363.27k
Avg Vol (10 day) 3676.08k
Shares Outstanding 533.57M
Float 30.91M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Sep 30, 2019) 41.31M
Short Ratio (Sep 30, 2019) 43.15
Short % of Float (Sep 30, 2019) 4N/A
Short % of Shares Outstanding (Sep 30, 2019) 43.90%
Shares Short (prior month Aug 30, 2019) 41.06M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 230/1
Last Split Date 3Jun 19, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-162.55%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -63.73M
Net Income Avi to Common (ttm)-58.7M
Diluted EPS (ttm)-2.4870
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.32M
Total Cash Per Share (mrq)0.33
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.50
Book Value Per Share (mrq)-0.59

Cash Flow Statement

Operating Cash Flow (ttm)-61.22M
Levered Free Cash Flow (ttm)-24.41M